Clinical Trials
6 trialsNCT04582539 2025-10-22
LIMBER
Incyte Corporation
Phase 1/2 Terminated
NCT03303950 2022-05-05
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis
University of Utah
Phase 2 Terminated
NCT01447914 2019-08-28
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00400686 2018-02-22
Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
The Cleveland Clinic
Phase NA Completed
NCT00416624 2017-02-10
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
Mayo Clinic
Phase 2 Completed
NCT00661999 2011-05-17
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
Mayo Clinic
Phase 3 Completed